Response to Letter to the Editor From Drs. Stöllberger and Finsterer: Original Publication: "Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, and Safety of Apixaban"
J Clin Pharmacol
.
2016 May;56(5):648-9.
doi: 10.1002/jcph.687.
Authors
Charles Frost
1
,
Ming Chang
1
,
Zhigang Yu
1
,
Andrew Shenker
1
,
Jessie Wang
1
,
Janice Pursley
1
,
Wonkyung Byon
2
,
Rebecca A Boyd
3
,
Frank LaCreta
1
Affiliations
1
Bristol-Myers Squibb, Princeton, NJ, USA.
2
Pfizer Global Research & Development, Groton, CT, USA.
3
Pfizer Global Innovative Pharma Business, Groton, CT, USA.
PMID:
27088780
DOI:
10.1002/jcph.687
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Renal Insufficiency*